A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome
Blood (2019) 134 (Supplement_1): 568.
Currently there are no citedby results. Try again later.
